In Vitro Metabolism and Analytical Characterization of SLU‐PP‐332 and SLU‐PP‐915: Novel Pan‐ERR Agonists With Doping Potential

Key Points

• Analysis reveals the metabolic pathways for SLU-PP-332 and SLU-PP-915, both pan-ERR agonists with potential doping applications.
• The study highlights that these new compounds could be misused for enhancing athletic performance, raising ethical concerns.
• Metabolism studies provide critical insights into how rapidly the compounds are processed in vitro, potentially influencing their effects.
• Identifying the characteristics of these substances may inform guidelines to combat their misuse in sports and athletics.